Nucleotide-processing enzyme

Nucleotide-processing enzymes encompass a variety of protein families that catalyze essential reactions in nucleotide metabolism, including the synthesis, modification, and degradation of DNA, RNA, and energy-carrying nucleotides like ATP[2][4][7]. Major subclasses include polymerases (which synthesize nucleic acids[10]), ligases (which join DNA or RNA fragments[8][10]), nucleases (which degrade nucleic acids), kinases (which transfer phosphate groups), and restriction enzymes (which cleave DNA at specific sequences[1]). By regulating nucleotide balance, these enzymes support genome maintenance, signal transduction, and cell viability. Aberrant activity or expression is linked to disease states such as cancer, infection, and genetic disorders; thus, they are frequent targets for diverse drug classes, especially antimetabolites and nucleoside analogues[4][2]. This entry covers a functional category rather than a specific molecule. For precise drug discovery or biomarker work, it is recommended to specify the individual enzyme or family (e.g., DNA polymerase, ribonucleotide reductase), as each has distinct roles, inhibitors, and biomarkers[4][2][10].

Other names

Nucleotide metabolism enzymeNucleotide synthesis enzymeNucleic acid-processing enzymeDNA/RNA-processing enzyme

Inhibition of nucleotide synthesis (antimetabolites); Blockade of DNA/RNA polymerization; Disruption of DNA repair or replication; Chain termination in viral DNA/RNA synthesis (nucleoside analogs).